Raytheon Technologies to Host 2021 Investor Meeting
Get Alerts RTX Hot Sheet
Overall Analyst Rating:
NEUTRAL ( Up)
Dividend Yield: 2.6%
EPS Growth %: +0.8%
Join SI Premium – FREE
WALTHAM, Mass., April 13, 2021 /PRNewswire/ -- Raytheon Technologies (NYSE: RTX) announced it will host an investor day on May 18, 2021 with presentations from management from 10:30 a.m. – 2:30 p.m. ET. During the event, Raytheon Technologies CEO Greg Hayes and other members of the executive team will provide details on the company's long-term growth strategy and outlook.
The meeting will be broadcast live on the Internet at investors.rtx.com and will be archived on the website afterward. Corresponding presentations will be available on the site prior to the meeting.
About Raytheon TechnologiesRaytheon Technologies Corporation is an aerospace and defense company that provides advanced systems and services for commercial, military and government customers worldwide. With four industry-leading businesses ― Collins Aerospace Systems, Pratt & Whitney, Raytheon Intelligence & Space and Raytheon Missiles & Defense ― the company delivers solutions that push the boundaries in avionics, cybersecurity, directed energy, electric propulsion, hypersonics, and quantum physics. The company, formed in 2020 through the combination of Raytheon Company and the United Technologies Corporation aerospace businesses, is headquartered in Waltham, Massachusetts.
Media ContactC: 860.493.4364
Investor ContactC: 781.522.5123
View original content:http://www.prnewswire.com/news-releases/raytheon-technologies-to-host-2021-investor-meeting-301268019.html
SOURCE Raytheon Technologies
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sharing Experiences for Mutual Success: Heilongjiang Ice and Snow Tourism link with Northern Europe as a silver silk ribbon
- SKT collaborates with Aptos Labs, Brevan Howard and Microsoft to bring global institutional finance on-chain with Aptos Ascend
- Global clinical development on Dengue antiviral candidate will start, Hyundai Bioscience strives to win emergency use authorization
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!